Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-673-3 | CAS number: 124-04-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP but overall good documentation, purity not specified, no positive control for every experiment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
Materials and methods
- Principles of method if other than guideline:
- Groups of 5 treated and 3 control animals were used. Animals were killed 6, 24 and 48 hours after a single administration in the acute study. In the subacute study 5 doses, 24 hours apart, were administered and animals were killed 6 hours after the last dose.
- GLP compliance:
- no
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- Adipic acid
- EC Number:
- 204-673-3
- EC Name:
- Adipic acid
- Cas Number:
- 124-04-9
- Molecular formula:
- C6H10O4
- IUPAC Name:
- adipic acid
- Details on test material:
- IUCLID4 Test substance: purity not specified
Constituent 1
- Specific details on test material used for the study:
- compound FDA 71-50, Adipic acid, food processing quality, as supplied by the Food and Drug Administration
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: gavage
- Duration of treatment / exposure:
- Acute study: single dosing; subacute study: once a day for 5 consecutive days
- Frequency of treatment:
- Acute study: single dosing; subacute study: once a day for 5 consecutive days
- Post exposure period:
- Animals were killed 6, 24 and 48 hours after a single administration in the acute study. In the subacute study 5 doses, 24 hours apart, were administered and animals were killed 6 hours after the last dose.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Test 1: acute and subacute: 3.75, 37.5, 375 mg/kg bw/day; Test 2: acute 5000 mg/kg bw and subacute 2500 mg/kg bw/day
Basis:
- No. of animals per sex per dose:
- Groups of 5 treated and 3 control animals were used.
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- positive control animals were treated with 0.3 mg/kg bw TEM (triethylenemelamine) by intraperitoneally incection
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- Four hours after the last compound administration, and two hours prior to killing, each animal was given 4 mg/kg bw of colcemid intraperitoneally in order to arrest the bone marrow cells in C-mitosis. The marrow "plug" was removed and aspirated into Hanks' balanced salt solution. The specimen were centrifuged and resuspended in hypotonic 0.5% KCl. The specimens were placed in a 37 degree Celsius water bath in order to swell the cells. Following centrifugation the cells were resuspended in a fixative (3:1 absolute methanol : glacial acetic acid) and again centrifuged. Cells were resuspended and placed at 4 degree Celsius overnight. The following day cells were again centrifuged and freshly prepared fixative was added. The suspension was dropped onto a slide and ignited by an alcohol burner and allowed to flame. Slides were stained with 5% Giemsa solution. The preparations were examined by microscopy. The chromosomes of each cell were counted and only diploid cells were analyzed. They were scored for chromatid gaps and breaks, chromosome gaps and breaks, reunions, cells with greater than ten aberrations, polyploidy, pulverization, and other chromosomal aberrations which were observed. Fifty metaphase spreads were scored per animal. Mitotic indices were obtained by counting at least 500 cells and the ratio of the number of cells in mitosis / the number of cells observed was expressed as the mitotic index. Negative and positive (TEM) controls were run in each experiment. Two tests were performed at different time intervals.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks:
- Triethyl Melamine (TEM)
Any other information on results incl. tables
Table 1: Acute study I with single gavage dosing (3.75, 37.5 and 375 mg/kg bw):
The negative control group cells contained no aberrations. Adipic acid produced no aberrations except for one cell containing a break in the 6-hour sample of the intermediate dose level. The expected severe chromosomal damage was observed for the positive control group (triethylene melamine treated animals). The mitotic indices
were within normal limits. Negative and positive controls were functional.
dosage (mg/kg bw) | time* | no. of animals | no. of cells per animal | mitotic index** | % cells with breaks | % cells with other aberrations | % total cells with aberrations |
negative control saline | 6/24/48 | 3/3/3 | 150 | 6/4/8 | 0/0/0 | 0/0/0 | 0/0/0 |
3.75 | 6/24/48 | 5/5/5 | 250 | 7/4/6 | 0/0/0 | 0/0/0 | 0/0/0 |
37.5 | 6/24/48 | 5/5/5 | 250 | 5/7/6 | 0.4/0/0 | 0/0/0 | 0/0/0 |
375 | 6/24/48 | 5/5/5 | 250 | 5/6/4 | 0/0/0 | 0/0/0 | 0/0/0 |
positive control TEM 0.3 |
48 | 5 | 250 | 4 | 0 | 22 | 45 |
* time of kill after single gavage application (hours)
**percent cells in mitosis: 500 cells observed/animal
Table 2: Subacute study I (5 days) with 5 gavage dosings (3.75, 37.5 and 375 mg7kg bw/day):
The negative control group and the low level test group contained no aberration. The intermediate level contained one cell with a reunion and one cell that
was polyploid. The highest level contained three cells with breaks and one fragment. These were considered to be within the normal limits of the
historical negative controls of the laboratory. Negative control was functional, no positive control.
dosage (mg/kg bw)# | no. of animals | no. of cells per animal | mitotic index** | % cells with breaks | % cells with reunion | % cells with other aberrations | % total cells with aberrations |
negative control saline | 3 | 150 | 6 | 0 | 0 | 0 | 0 |
3.75 | 5 | 250 | 5 | 0 | 0 | 0 | 0 |
37.5 | 5 | 250 | 5 | 0 | 0.4 | 0.4 (P) | 0.8 |
375 | 5 | 250 | 4 | 1.2 | 0 | 0.4 (f) | 1.6 |
# dosage as gavage application 1x/day for 5 days
P - cells that have polyploidy
f - cells that have fragmentaion
** percent cells in mitosis: 500 cells observed/animal
Table 3: Acute study II: Adipic acid was administered at a single dose of 5000 mg/kg bw. The compound produced no aberrations except for 3 cells with polyploidy (2 in the 6-hour sample and 1 in the 24-hour). Neither the variety nor the number of these aberrations differed significantly from the negative controls (polyploidy observed in 4 cells). Negative and positive controls were functional.
dosage (mg/kg bw) | time* | no. of animals | no. of cells per animal | mitotic index** | % cells with breaks | % cells with other aberrations | % total cells with aberrations |
negative control saline | 6/24/48 | 3/3/3 | 150 | 7.47/4.5/4.5 | 0/0/0 | 1pp/2pp/1pp | 1 (0.66)/2 (1.33)/1 (0.66) |
5000 | 6/24/48 | 5/5/5 | 250 | 5.51/4.03/4.13 | 0/0/0 | 2pp/1pp/0 | 2 (0.8)/1 (0.4)/0 |
positive control TEM 0.3 |
24 | 5 | 250 | 1.62 | 4 (1.6) | >27 (10.8), 9f, 1pp | 86 (34.4) |
P - cells that have polyploidy
f - cells that have fragmentaion
** percent cells in mitosis: at least 500 cells observed/animal
Table 4: Subacute study (5 days, 2500 mg/kg bw/day). Only 218 metaphases have been evaluated. The compound produced no aberrations except for 1 cell with polyploidy. Polyploidy was also observed in the negative control group. These are considered to be within the normal limits of the historical negative controls. Negative control was functional, no positive
control.
dosage (mg/kg bw)# | no. of animals | no. of cells per animal | mitotic index** | % cells with breaks | % cells with reunion | % cells with other aberrations | % total cells with aberrations |
negative control saline | 3 | 150 | 5.33 | 0 | 0 | 1 (pp) (0.66) | 1 (0.66) |
2500 | 5 | 218 | 2.98 | 0 | 0 | 1 (pp) (0.46) | 1 (0.46) |
P - cells that have polyploidy
f - cells that have fragmentaion
** percent cells in mitosis: 500 cells observed/animal
In summary, adipic acid can be considered non-mutagenic as measured by the cytogenetic test.
Applicant's summary and conclusion
- Executive summary:
Adipic acid was not mutagenic in in vivo cytogenetic studies where groups of five male rats were gavaged with adipic acid doses up to 5000 mg/kg bw (acute studies) and with doses up to 2500 mg/kg bw/day (five-days subacute studies). 200 to 500 metaphase chromosomes of bone marrow cells per dose were scored for chromatid gaps and breaks, chromosome gaps and breaks, reunions, cells with greater than ten aberrations, polyploidy, pulverization and other chromosomal aberrations. The mitotic indices for all dose groups were considered to be within the normal limits of the controls and there was no evidence of chromosomal damage. The positive control groups, performed only during the acute studies, were functional (Litton Bionetics, Inc. 1974).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.